T#]<~X:4R@K^Z_+E+AD1S-LQO]#P(DT1OR0*
SYSTEM PROCESSING...
T#]<~X:4R@K^Z_+E+AD1S-LQO]#P(DT1OR0*
SYSTEM PROCESSING...
Posted: 2025-04-22 13:03:00 UTC
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
Status
Last Updated
2025-04-22 13:03:14 UTC
Verified By
Rollup News
Granzyme K (GZMK) activates the complement system, leading to tissue damage in autoimmune diseases. Targeting GZMK may offer a therapeutic approach to inhibit this pathway while preserving immune function.
GZMK activates the complement system.
GZMK drives tissue damage in autoimmune diseases.
Targeting GZMK could lead to new therapies.
Potential therapies could inhibit the harmful pathway while preserving immune function.
Autoimmune diseases
Tissue damage
Inflammatory pathology